论文部分内容阅读
目的分析阿司匹林联合硫酸氢氯吡格雷口服治疗脑梗死的有效性和安全性。方法 100例脑梗死患者,根据治疗方法的不同将患者分成对照组和实验组,每组50例。对照组患者选择阿司匹林治疗,实验组患者选择阿司匹林联合硫酸氢氯吡格雷口服治疗,对两组患者的临床治疗效果和不良反应发生情况进行观察。结果实验组患者治疗总有效率为98.0%,显著高于对照组患者的62.0%,差异具有统计学意义(P<0.05)。两组患者在治疗过程中均没有出现显著不良反应。结论对脑梗死患者进行治疗时采用阿司匹林联合硫酸氢氯吡格雷口服治疗,效果比较理想,安全可靠,值得临床推广。
Objective To analyze the efficacy and safety of aspirin combined with clopidogrel hydrogen sulfate in the treatment of cerebral infarction. Methods 100 cases of cerebral infarction patients, according to the different treatment methods will be divided into control group and experimental group, 50 cases in each group. Patients in the control group were treated with aspirin. Patients in the experimental group were treated with aspirin and clopidogrel bisulfate orally, and the clinical effects and adverse reactions of the two groups were observed. Results The total effective rate of the experimental group was 98.0%, which was significantly higher than that of the control group (62.0%), the difference was statistically significant (P <0.05). Two groups of patients in the course of treatment were no significant adverse reactions. Conclusion Aspirin combined with clopidogrel hydrogen sulfate in the treatment of patients with cerebral infarction, the effect is ideal, safe and reliable, worthy of clinical promotion.